INCY vs TDOC · P/E 14, rev $5.14B vs rev $1.22B
Incyte Corporation (INCY) versus Teladoc Inc (TDOC) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Teladoc Inc (TDOC) is a health information services company listed on NYSE.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported TDOC revenue for 2026-06-30 was $1.22B. Net income was -$102.7M. Revenue was up 98.9% from 2026-03-31 to 2026-06-30. TDOC currently screens at market cap $1.38B.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. TDOC currently screens at market cap $1.38B.
Not investment advice. Open the INCY and TDOC stock pages for the full models.
Not investment advice.